

Please try another search
Duchenne muscular dystrophy (“DMD”) is a rare genetic disease and a severe form of muscular dystrophy, primarily affecting males. It progressively weakens and degenerates skeletal and...
The biotech sector was in focus with regular pipeline updates. While Sarepta Therapeutics, Inc. (NASDAQ:SRPT) and Solid Biosciences (NASDAQ:SLDB) gained on positive data, Anika Therapeutics, Inc. ...
Sarepta Therapeutics Inc. (NASDAQ:SRPT) was a star performer in Tuesday’s trading session, as the stock skyrocketed as much as 57.7% to a new high of $176.50 but closed a little lower, rising...
Shares of Solid Biosciences Inc. (NASDAQ:SLDB) surged 10.9% after the company announced that the FDA has lifted the clinical hold on its phase I/II trial, IGNITE DMD, for its experimental candidate,...
Investors in Sarepta Therapeutics, Inc. (NASDAQ:SRPT) need to pay close attention to the stock based on moves in the options market lately. That is because the Jun 22, 2018 $100.00 Call had some of...
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) announced that it has entered into a long-term strategic manufacturing partnership with privately-held Brammer Bio for the manufacturing and commercial...
Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT) have been rising so far this year. The biotech company’s stock has rallied 64.7%, significantly outperforming the 9.6% decline of the...
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) incurred a loss of 28 cents per share in the first quarter of 2017, narrower than the year-ago loss of 57 cents and the Zacks Consensus Estimate of a loss of...
Pfizer Inc. (NYSE:PFE) has announced initiation of dosing in a phase Ib study, evaluating its mini-dystrophin gene therapy candidate, PF-06939926, for the treatment of boys aged from five to 12...
Shares of Solid Biosciences Inc. (NASDAQ:SLDB) tanked 54.2% after the FDA notified the company that its phase I/II trial, IGNITE DMD, on lead candidate SGT-001 has been put on clinical hold. ...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review